Kruk Emilia, Kobryń Konrad, Rykowski Paweł, Szczepankiewicz Benedykt, Patkowski Waldemar, Zieniewicz Krzysztof
Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
Department of Pathomorphology, Medical University of Warsaw, Warsaw, Poland.
Front Surg. 2022 May 2;9:875782. doi: 10.3389/fsurg.2022.875782. eCollection 2022.
Calcifying nested stromal epithelial tumor (CNSET) is an extremely rare diagnosis among patients treated for primary hepatic neoplasms. There are only 45 cases reported worldwide. Histopathological characteristics are well-demarcated nests of spindle and epithelioid cells in a dense desmoplastic stroma with variable calcification and ossification. It is mostly diagnosed in children and young females. Treatment strategies implemented for the management of CNSET include radiofrequency ablation, transarterial chemoembolization, surgical resection, adjuvant and neoadjuvant chemotherapy, and liver transplantation. Given the small number of available cases, there are still no established standards of treatment for this neoplasm.
A 28-year-old female diagnosed with CNSET presented mild abdominal pain, with normal laboratory values. The tumor was initially deemed unresectable, therefore, the patient was disqualified from liver resection. Further deterioration of the patient's clinical condition and local tumor progression led to qualification for liver transplantation. The patient underwent liver transplantation 1 year following initial diagnosis and a 12 months recurrence-free period was observed. During the course of treatment, she did not receive systemic chemotherapy, radiotherapy, or loco-regional treatment.
Multiple strategies have been implemented for the treatment of CNSET, with liver resection providing the best outcomes. Transarterial chemoembolization, radiofrequency ablation, and radiotherapy are reported to be insufficient in the management of this tumor. Various chemotherapy regimens turned out to be ineffective as well. There have been only eight reported cases of patients undergoing liver transplantation for CNSET, with tumor recurrence in two cases. CNSET appears to be a neoplasm with low malignancy potential, although an aggressive progression has subsequently been reported. Further investigation is still required in this field.
在原发性肝肿瘤患者中,钙化性巢状间质上皮瘤(CNSET)是一种极为罕见的诊断。全球仅报道了45例。组织病理学特征为在致密的促纤维组织增生性间质中,有界限清楚的梭形和上皮样细胞巢,伴有不同程度的钙化和骨化。其多见于儿童和年轻女性。用于管理CNSET的治疗策略包括射频消融、经动脉化疗栓塞、手术切除、辅助和新辅助化疗以及肝移植。鉴于可用病例数量较少,该肿瘤仍未确立治疗标准。
一名28岁诊断为CNSET的女性出现轻度腹痛,实验室检查值正常。肿瘤最初被认为无法切除,因此该患者不符合肝切除条件。患者临床状况的进一步恶化和局部肿瘤进展导致其符合肝移植条件。患者在初次诊断后1年接受了肝移植,观察到12个月的无复发生存期。在治疗过程中,她未接受全身化疗、放疗或局部治疗。
已对CNSET实施了多种治疗策略,肝切除的效果最佳。据报道,经动脉化疗栓塞、射频消融和放疗在该肿瘤的管理中不足。各种化疗方案也被证明无效。仅有8例报道的患者因CNSET接受了肝移植,其中2例出现肿瘤复发。尽管随后有侵袭性进展的报道,但CNSET似乎是一种恶性潜能较低的肿瘤。该领域仍需进一步研究。